You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemolysis

Showing 26 - 50 of 1,057
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MATRIX "Renal and Systemic Thrombotic Microangiopathy"

Recruiting
  • Thrombotic Microangiopathy
  • +4 more
  • Collecting datas
  • Tours, France
    Department of Nephrology, University Hospital of Tours
Aug 10, 2023

Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 21, 2023

Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 20, 2023

Hypertensive Emergency-associated Hemolytic Uremic Syndrome Trial in Paris (Soliris®, Renin angiotensin system blockers)

Not yet recruiting
  • Hypertensive Emergency-associated Hemolytic Uremic Syndrome
  • Paris, France
    Tenon Hospital
Feb 3, 2023

aHUS - Atypical Hemolytic Uremic Syndrome Trial (NM8074)

Not yet recruiting
  • aHUS - Atypical Hemolytic Uremic Syndrome
  • (no location specified)
Jan 23, 2023

Hemolysis, Exercise, Sleep Disorder Trial in Hualien City (Cycling exercise)

Completed
  • Hemolysis
  • +4 more
  • Cycling exercise
  • Hualien City, Taiwan
    Buddhist Tzu Chi General Hospital
Mar 1, 2022

Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Blood sampling and urine analysis
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 28, 2023

Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • (no location specified)
Mar 24, 2023

Atypical Hemolytic Uremic Syndrome Trial (Iptacopan)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • (no location specified)
Jun 29, 2023

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Hereditary Spherocytosis Trial in Lyon (blood sample, Pulse wave velocity)

    Recruiting
    • Hereditary Spherocytosis
    • blood sample
    • Pulse wave velocity
    • Lyon, France
    • +1 more
    Mar 15, 2022

    After COVID-19 Vaccination Among Patients Under Hemodialysis

    Completed
    • Covid19
    • +3 more
    • Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)
    • Seoul, Korea, Republic of
      Hanyang University Seoul Hospital
    Mar 16, 2022

    Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia Trial (povetacicept)

    Not yet recruiting
    • Immune Thrombocytopenia
    • +3 more
    • (no location specified)
    Mar 9, 2023

    Anemia, Hemolytic, Autoimmune Trial (Nipocalimab)

    Temporarily not available
    • Warm Autoimmune Hemolytic Anemia
    • (no location specified)
    Nov 15, 2022

    Atypical Hemolytic Uremic Syndrome Trial (Iptcaopan 200 mg)

    Not yet recruiting
    • Atypical Hemolytic Uremic Syndrome
    • Iptcaopan 200 mg
    • (no location specified)
    Mar 21, 2023

    Pulmonary Hypertension, Sickle Cell Disease, Thalassemia Trial in Oakland (L-Glutamine)

    Completed
    Has Results
    • Pulmonary Hypertension
    • +2 more
    • Oakland, California
      Children's Hospital & Research Center Oakland
    Jun 8, 2021

    Hemolysis, COVID-19 Trial in Changsha, Chengdu, Guiyang (coadministration, COVID-19 vaccine, IIV4+PPV23)

    Not yet recruiting
    • Hemolysis
    • COVID-19
    • coadministration
    • +2 more
    • Changsha, China
    • +2 more
    Aug 2, 2022

    Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • +3 more
    • Ibrutinib 420 mg
    • (no location specified)
    Jan 12, 2023

    Thromboembolism, Hemolysis, Stroke Trial in United States (Lavare On, Lavare Off)

    Terminated
    • Thromboembolism
    • +2 more
    • Lavare On
    • Lavare Off
    • Birmingham, Alabama
    • +3 more
    Jan 13, 2022

    Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Singapore (Ianalumab, Placebo)

    Recruiting
    • Warm Autoimmune Hemolytic Anemia (wAIHA)
    • Ianalumab
    • Placebo
    • Singapore, Singapore
      Novartis Investigative Site
    Jan 5, 2023

    Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia Trial in Dijon (treatment "intervention",

    Recruiting
    • Prolonged Anticoagulation
    • +2 more
    • treatment "intervention"
    • +2 more
    • Dijon, France
      Chu Dijon Bourgogne
    Jul 4, 2022

    Warm Antibody Autoimmune Hemolytic Anemia Trial (HMPL-523(300mg PO QD), Placebo)

    Not yet recruiting
    • Warm Antibody Autoimmune Hemolytic Anemia
    • HMPL-523(300mg PO QD)
    • Placebo
    • (no location specified)
    Sep 7, 2022

    Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment Trial in Zhoukou, Tianjin (Linperlisib)

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • Failure of Two Rounds of Treatment
    • Zhoukou, Henan, China
    • +1 more
    Jan 7, 2023

    Sickle Cell Disease, Hemolytic Anemia Trial run by the NHLBI (Mitapivat)

    Active, not recruiting
    • Sickle Cell Disease
    • Hemolytic Anemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Sickle Cell Disease Trial in Créteil (Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease)

    Not yet recruiting
    • Sickle Cell Disease
    • Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease
    • Créteil, France
      Hospital Henri Mondor
    Jan 5, 2022